Digitale Gesundheitsanwendungen in der Diabetologie

ZUSAMMENFASSUNG

Stand September 2023 sind bereits 3 Diabetes-DiGAs zugelassen – HelloBetter (Zulassung Dezember 2021), Vitadio (vorläufige Zulassung April 2022) und mebix (vorläufige Zulassung Juli 2023). Des Weiteren gibt es mit Zanadio (Zulassung November 2020) und Oviva Direkt (Zulassung Oktober 2021) 2 Adipositas-DiGAs, welche ebenfalls Patienten mit Diabetes mellitus unterstützen. Viele weitere DiGAs sind in den Startlöchern und werden im Laufe des nächsten halben Jahres das DiGA-Verzeichnis füllen.

Publication History

Article published online:
17 October 2023

• Literatur

• 1 Cuijpers P. et al Psychological treatment of depression: results of a series of meta-analyses. Nord J Psychiatry 2011; 65: 354-364
• 2 Mehl N. et al Unhealthy yet Avoidable-How Cognitive Bias Modification Alters Behavioral and Brain Responses to Food Cues in Individuals with Obesity. Nutrients 2019; 11: 874
• 3 Mehl N. et al Retraining automatic action tendencies in obesity. Physiol Behav 2018; 192: 50-58
• 4 Forkmann K. et al Introducing zanadio-A Digitalized, Multimodal Program to Treat Obesity. Nutrients 2022; 14: 3172
• 5 McDiarmid S. et al Intermittent Versus Continuous Low-Energy Diet in Patients With Type 2 Diabetes: Protocol for a Pilot Randomized Controlled Trial. JMIR Res Protoc 2021; 10: e21116
• 6 Huntriss R. et al A service evaluation exploring the effectiveness of a locally commissioned tier 3 weight management programme offering face-to-face, telephone and digital dietetic support. Clin Obes 2021; 11: e12444
• 7 Haas K. et al Effectiveness and Feasibility of a Remote Lifestyle Intervention by Dietitians for Overweight and Obese Adults: Pilot Study. JMIR Mhealth Uhealth 2019; 07: e12289
• 8 Weishaupt E. et al Online nutrition counselling on weight loss. Experiences of overweight and obese adults. Ernahrungs Umschau 2020; 67: 108-114
• 9 Timpel P. et al Mapping the Evidence on the Effectiveness of Telemedicine Interventions in Diabetes, Dyslipidemia, and Hypertension: An Umbrella Review of Systematic Reviews and Meta-Analyses. J Med Internet Res 2020; 22: e16791
• 10 Narozna L.. Personalized technologies and their use to change attitudes and behavior in patients with diabetes and prediabetes Personalizované technologie a jejich užití ke změně postojů a chování u pacientů s diabetem a prediabetem [online]. In: Faculty of Medicine 2021, Masaryk University, Brno, 2021. Online. https://is.muni.cz/th/m7ygo/ (https://is.muni.cz/th/m7ygo/?fakulta=1433;lang=en) (letzter Zugriff: 14.09.2023)
• 11 Nundy S. et al How do mobile phone diabetes programs drive behavior change? Evidence from a mixed methods observational cohort study. Diabetes Educ 2014; 40: 806-819
• 12 Greenwood DA. et al A Systematic Review of Reviews Evaluating Technology-Enabled Diabetes Self-Management Education and Support. J Diabetes Sci Technol 2017; 11: 1015-1027
• 13 Moravcova K. et al Comparing Digital Therapeutic Intervention with an Intensive Obesity Management Program: Randomized Controlled Trial. Nutrients 2022; 14: 2005
• 14 Bretschneider MP. et al Impact of a Digital Lifestyle Intervention on Diabetes Self-Management: A Pilot Study. Nutrients 2022; 14: 1810
• 15 Reinhardt G.. Dissertationsschrift: Evaluation der Wirksamkeit der App VIDEAbewegt zur Steigerung der körperlichen Aktivität über den Zeitraum von einem Jahr. In: Medizinische Klinik III. 2021, Technical University of Dresden, Medical Faculty Carl Gustav Carus: Dresden. p. 124
• 16 Fischer T. et al Video-based smartphone app (‘VIDEA bewegt’) for physical activity support in German adults: a study protocol for a single-armed observational study. BMJ Open 2020; 10: e034027
• 17 Schwarz PEH. et al Prävention des Diabetes ist erwachsen geworden. Deutscher Gesundheitsbericht Diabetes 2020. 2020
• 18 Fischer T.. Dissertationsschrift: Evaluation eines App-basierten Bewegungsprogramms für Versicherte gesetzlicher Krankenkassen. In: Medizinische Klinik III. 2021, Technical University of Dresden, Medical Faculty Carl Gustav Carus: Dresden. p. 131
• 19 Fischer T. et al Video-based smartphone app (‘VIDEA bewegt’) for physical activity support in German adults: a single-armed observational study. BMJ Open 2022; 12: e052818
• 20 Reinhardt G. et al Long-Term Effects of a Video-Based Smartphone App („VIDEA Bewegt“) to Increase the Physical Activity of German Adults: A Single-Armed Observational Follow-Up Study. Nutrients 2021; 13: 4215
• 21 Brandt CJ. et al Evaluation of the Clinical and Economic Effects of a Primary Care Anchored, Collaborative, Electronic Health Lifestyle Coaching Program in Denmark: Protocol for a Two-Year Randomized Controlled Trial. JMIR Res Protoc 2020; 09: e19172
• 22 Haste A. et al Web-Based Weight Loss Intervention for Men With Type 2 Diabetes: Pilot Randomized Controlled Trial. JMIR Diabetes 2017; 02: e14
• 23 Komkova A. et al Electronic Health Lifestyle Coaching Among Diabetes Patients in a Real-Life Municipality Setting: Observational Study. JMIR Diabetes 2019; 04: e12140
• 24 Hesseldal L. et al Long-term Weight Loss in a Primary Care-Anchored eHealth Lifestyle Coaching Program: Randomized Controlled Trial. J Med Internet Res 2022; 24: e39741
• 25 Christensen JR. et al Reversing Type 2 Diabetes in a Primary Care-Anchored eHealth Lifestyle Coaching Programme in Denmark: A Randomised Controlled Trial. Nutrients 2022; 14: 3424
• 26 Sand L. et al Health Economic Analysis of the telemedicine based ESYSTA®-System with a connected smart insulin pen – Potential monetary savings from using an Integrated Diabetes Management System. In: ATTD, ATTD, Editor 2019: Berlin
• 27 Schildt J, Mertens H. Das ESYSTA-START-Projekt – Telediabetologisches Chronic Care Management als Versorgungsoption im ambulanten Sektor?. Diabetes aktuell 2013; 13: 354-359
• 28 Sand L. et al Mit E-Health Kosten sparen. Ökonomische Effekte einer dauerhaften HbA1c-Absenkung bei Patienten mit Diabetes mellitus. Diabetes aktuell 2017; 15: 354-358
• 29 Unnikrishnan AG. et al Impact of My Dose Coach App Frequency of Use on Clinical Outcomes in Type 2 Diabetes. Diabetes Ther 2022; 13: 983-993
• 30 Debong F. et al Real-World Assessments of mySugr Mobile Health App. Diabetes Technol Ther 2019; 21 (Suppl. 02) S235-S240
• 31 Maharaj A. et al Comparing Two Commercially Available Diabetes Apps to Explore Challenges in User Engagement: Randomized Controlled Feasibility Study. JMIR Form Res 2021; 05: e25151
• 32 Rama Chandran S. et al Disordered eating in women with type 1 diabetes: Continuous glucose monitoring reveals the complex interactions of glycaemia, self-care behaviour and emotion. Diabet Med 2021; 38: e14446
• 33 Kebede MM, Pischke CR. Popular Diabetes Apps and the Impact of Diabetes App Use on Self-Care Behaviour: A Survey Among the Digital Community of Persons With Diabetes on Social Media. Front Endocrinol (Lausanne) 2019; 10: 135
• 34 Eichinger V. et al Improved glycemic control and diabetes distress after using an m-health application: A preparation analysis for the digital health care act in Germany. In: ATTD 2021, virtual congress 2021. Online. https://doi.org/10.1089/dia.2021.2525.abstracts (letzter Zugriff: 14.09.2023)
• 35 Das Fast-Track-Verfahren für digitale Gesundheitsanwendungen (DiGA) nach § 139e SGB V, Ein Leitfaden für Hersteller, Leistungserbringer und Anwender, Version 3.1 vom 18.03.2022. https://www.bfarm.de/SharedDocs/Downloads/DE/Medizinprodukte/diga_leitfaden.html?nn=597198 (letzter Zugriff: 27.09.2023)